World Drug Safety Congress Americas in Boston this Oct will bring together 600+ top leaders in biopharma to discuss the key challenges they are facing in pharmacovigilance and device safety https://t.co/dpCtE5PIet @WDS_event#WDS#pharmacovigilance#lifesciences#biotechnology
Pharma companies outsourcing clinical research support without focusing on safety are paying the price explains @arriello_group Pharmacovigilance Manager and EU QPPV at Arriello, Natalia Vlcek-in @PharmaReview https://t.co/ZkOox2eIFh #clinicalresearch#outsourcing#safety
Marketing Medical Cannabis in Europe.
@arriello director of drug safety Peter Kohut gives his advice in the latest issue of International Pharmaceutical Industry https://t.co/damMDBE8bC #cannabis#lifesciences#regulatory
Our head of clinical safety management, Alexandra Iuliana Lazar-Giannakopoulou reflects on the MHRA's updated guidelines to assist companies involved in clinical trials disrupted as a result of the Covid-19 pandemic. https://t.co/s2zjtmpcZz #clinicaltrials#pandemic#guidelines